Elizabeth Richter
Retina Specialist · Sarasota, FLNPI 1497076335
Payments from drug & device makers
Across 166 payments — averaging $411.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma Global Development$28K
- Regeneron$25K
- Astellas Pharma US Inc$8K
- Alimera Sciences, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Dutch Ophthalmic, USA$1K
- plus $3K from 16 others
What the payments were for
- Consulting fees$7,50049%
- Speaking & faculty fees$1,3699%
- Travel & lodging$8405%
- Food & beverage$5,59637%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma Global Development | 5 | $27,728 |
| Regeneron | 31 | $25,394 |
| Astellas Pharma US Inc | 17 | $8,052 |
| Alimera Sciences, Inc. | 7 | $1,319 |
| Regeneron Healthcare Solutions, Inc. | 29 | $1,290 |
| Dutch Ophthalmic, USA | 10 | $1,253 |
| Genentech USA, Inc. | 20 | $710 |
| AbbVie(2 entities) | 13 | $690 |
| Apellis Pharmaceuticals, Inc. | 7 | $579 |
| Mallinckrodt Hospital Products Inc. | 5 | $224 |
| Coherus Oncology, Inc. | 3 | $194 |
| Notal Vision, Inc. | 2 | $186 |
| Johnson & Johnson Vision Care, Inc. | 1 | $138 |
| Novartis | 6 | $132 |
| Beaver-visitec International, Inc. | 1 | $116 |
| ANI Pharmaceuticals, Inc. | 1 | $109 |
| Sight Sciences, Inc. | 1 | $93 |
| Sandoz | 1 | $38 |
| Bausch & Lomb Americas Inc. | 2 | $38 |
| Alcon | 2 | $34 |
| Convatec Inc. | 1 | $28 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Izervay$7,636
- Iluvien$1,200
- EVA, combined machine$840
- TISSUEBLUE$840
- Syfovre$492
- EYLEA$487
- OZURDEX$367
- EYLEA HD$365
- Lucentis$213
- Acuvue$138
- Cimerli$125
- ACTHAR$123
- XEN GLAUCOMA TREATMENT SYSTEM$123
- VABYSMO$113
- PURIFIED CORTROPHIN GEL$109
How this compares
$68,362 in reported general payments places this provider in the 70th percentile of 118 retina specialist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 83 | $3,586 |
| Difluprednate | 35 | $3,481 |
| Dorzolamide Hcl | 51 | $681 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 57 | $607 |
| Brimonidine Tartrate | 19 | $589 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 28 | $452 |
| Timolol Maleate | 42 | $449 |
| Ketorolac Tromethamine | 22 | $371 |
| Latanoprost | 58 | $318 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Sarasota
- Keye WongSarasota$23K
- Tanuj BankerSarasota$16K
- John NiffeneggerSarasota$16K
- Shailesh GuptaDeerfield Beach$18.8M
- Vrinda HershbergerMelbourne$8.2M
- Sunil GuptaPensacola$8.1M
- Stuart BurgessPlantation$4.6M
- Eduardo UchiyamaFt Lauderdale$4.1M
- Drew BawcombeDeerfield Beach$2M
- Dana DeupreeSpring Hill$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.